Premenopausal HR+/HER2- Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch Premenopausal HR+/HER2- Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study (NCT04819243) | Samsung Medical Center | 2021-08-25 |
Track Premenopausal HR+/HER2- Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.